Dasanu, Constantin A <br/><br/>
Pyoderma gangrenosum due to lenalidomide use for multiple myeloma.  [electronic resource] 

 -  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners  Dec 2015 
 - 471-3 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1477-092X 
<br/><br/><label>Standard No.: </label>10.1177/1078155214541975  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--adverse effects<br/>Blood Cell Count<br/>Fatal Outcome<br/>Humans<br/>Knee--pathology<br/>Lenalidomide<br/>Male<br/>Multiple Myeloma--complications<br/>Pyoderma Gangrenosum--chemically induced<br/>Skin--pathology<br/>Thalidomide--adverse effects